TLRY EBITDA | Tilray Brands, Inc.

Tilray Brands, Inc. (TLRY) EBITDA

2026-02-28: Basis Reported; EBITDA (m); Operating income -$26.39M; Depreciation and amortization (m).
2025-11-30: Basis Reported; EBITDA (m); Operating income -$22.28M; Depreciation and amortization (m).
2025-08-31: Basis Reported; EBITDA (m); Operating income $2.09M; Depreciation and amortization (m).
2025-02-28: Basis Reported; EBITDA (m); Operating income -$759.93M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2016-12-31 to 2022-08-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-02-28	Reported	(m)	-$26.39M	(m)	$206.73M	(m)	(m)	-$21.94M*	$151.78M	$62.00K	(m)	$1.97M
2025-11-30	Reported	(m)	-$22.28M	(m)	$217.51M	(m)	(m)	-$8.54M*	$160.01M	$78.00K	(m)	$3.55M
2025-08-31	Reported	(m)	$2.09M	(m)	$209.50M	(m)	(m)	-$1.34M	$152.03M	$41.00K	(m)	-$2.29M
2025-02-28	Reported	(m)	-$759.93M	(m)	$185.78M	(m)	(m)	-$5.76M*	$133.77M	$85.00K	(m)	$1.20M
2024-11-30	Reported	(m)	-$42.22M	(m)	$210.95M	(m)	(m)	-$40.72M*	$149.73M	$60.00K	(m)	$2.04M
2024-08-31	Reported	(m)	-$36.57M	(m)	$200.04M	(m)	(m)	-$35.31M	$140.34M	$105.00K	(m)	$886.00K
2024-02-29	Reported	(m)	-$82.10M	(m)	$188.34M	(m)	(m)	-$15.36M*	$138.94M	$106.00K	(m)	-$2.87M
2023-11-30	Reported	(m)	-$41.76M	(m)	$193.77M	(m)	(m)	-$30.41M*	$146.36M	$56.00K	(m)	-$3.38M
2023-08-31	Reported	(m)	-$34.36M	(m)	$176.95M	(m)	(m)	-$15.84M	$132.75M	$79.00K	(m)	$7.26M
2023-02-28	Reported	(m)	-$1.21B	(m)	$145.59M	(m)	(m)	-$18.63M*	$157.29M	$171.00K	(m)	-$10.81M
2022-11-30	Reported	(m)	-$51.79M	(m)	$144.14M	(m)	(m)	$29.21M*	$101.25M	$165.00K	(m)	$11.71M
2022-08-31	Reported	$12.89M	(m)	(m)	(m)	8.41%	(m)	-$46.27M	$104.60M	$166.00K	(m)	$7.21M
2022-05-31	Reported	-$426.66M	(m)	(m)	(m)	-278.27%	(m)	(m)	(m)	(m)	(m)	(m)
2022-02-28	Reported	$18.94M*	-$18.08M	$37.02M*	$151.87M	12.47%*	(m)	-$46.39M*	$112.04M	$164.00K	(m)	-$1.83M
2021-11-30	Reported	-$18.06M*	-$55.53M	$37.47M*	$155.15M	-11.64%*	(m)	-$17.12M*	$122.39M	$515.00K	(m)	-$5.67M
2021-08-31	Reported	-$30.04M	(m)	(m)	(m)	-17.88%	(m)	-$93.23M	$117.07M	$785.00K	(m)	$4.76M
2021-05-31	Reported	-$49.15M	(m)	(m)	(m)	-34.55%	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Reported	-$68.4M	(m)	(m)	(m)	-142.44%	$2.47M	-$13.01M	$34.52M	$1.20M	(m)	(m)
2021-02-28	Reported	-$3.77M*	-$24.05M	$20.28M*	$123.90M	-3.04%*	(m)	$696.00K*	$93.44M	$127.00K	(m)	$6.31M
2020-12-31	Reported	-$16.86M	(m)	(m)	(m)	-29.81%	(m)	(m)	(m)	(m)	(m)	(m)
2020-11-30	Reported	-$13.93M*	-$25.96M	$12.03M*	$129.46M	-10.76%*	(m)	$2.44M*	$94.18M	$225.00K	(m)	-$14.19M
2020-09-30	Reported	-$27.43M*	-$32.77M	$5.35M*	(m)	(m)	$11.87M*	-$13.98M*	(m)	$921.00K	(m)	(m)
2020-08-31	Reported	$2.51M	(m)	(m)	(m)	2.13%	(m)	-$56.10M	$82.55M	$120.00K	(m)	-$5.83M
2020-06-30	Reported	-$71.50M*	-$75.82M	$4.33M*	(m)	(m)	$9.20M*	-$36.47M*	(m)	$652.00K	(m)	(m)
2020-03-31	Reported	-$66.69M	(m)	(m)	(m)	-128.00%	$18.29M	-$54.03M	$41.23M	$1.35M	(m)	(m)
2019-12-31	Reported	-$213.56M	(m)	(m)	(m)	-455.00%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$19.09M*	-$23.79M	$4.70M*	(m)	(m)	$24.16M*	-$57.03M*	(m)	$2.31M	(m)	(m)
2019-06-30	Reported	-$29.97M*	-$32.96M	$2.99M*	(m)	(m)	$17.25M*	-$85.39M*	(m)	$1.53M	(m)	(m)
2019-03-31	Reported	-$25.67M	(m)	(m)	(m)	-111.43%	$9.02M	-$24.84M	(m)	$1.05M	(m)	(m)
2018-12-31	Reported	-$22.09M	(m)	(m)	(m)	-142.21%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$18.61M*	-$20.01M	$1.40M*	(m)	(m)	$9.84M*	-$23.54M*	(m)	$802.00K	(m)	$24.00K
2018-06-30	Reported	-$10.32M*	-$10.99M	$669.00K*	(m)	(m)	$15.38M*	-$1.18M*	(m)	$639.00K	(m)	$63.00K
2018-03-31	Reported	-$3.26M	(m)	(m)	(m)	-41.76%	$12.86M	-$1.73M	(m)	$975.00K	(m)	(m)
2017-12-31	Reported	-$2.14M	(m)	(m)	(m)	-41.91%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$1.74M*	-$2.18M	$447.00K*	(m)	(m)	$2.46M*	-$4.09M*	(m)	$729.00K	(m)	$0.00
2017-06-30	Reported	(m)	-$2.32M	(m)	(m)	(m)	(m)	(m)	(m)	$1.04M	(m)	$0.00
2017-03-31	Reported	(m)	-$388.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-05-31	Reported	(m)	-$63.03M	(m)	$915.45M	(m)	(m)	-$69.14M	$655.01M	$361.00K	(m)	$17.10M
2025-05-31	Reported	(m)	-$2.28B	(m)	$821.31M	(m)	(m)	-$94.60M	$580.74M	$284.00K	(m)	-$121.02M
2024-05-31	Reported	(m)	-$174.75M	(m)	$788.94M	(m)	(m)	-$30.91M	$565.59M	$635.00K	(m)	-$26.62M
2023-05-31	Reported	(m)	-$1.37B	(m)	$627.12M	(m)	(m)	$7.91M	$480.16M	$682.00K	(m)	-$7.18M
2022-05-31	Reported	-$455.81M	(m)	(m)	(m)	-72.54%	(m)	-$177.26M	$511.56M	$1.52M	(m)	-$6.54M
2021-05-31	Reported	-$64.34M	(m)	(m)	(m)	-12.54%	(m)	-$44.72M	$389.90M	$830.00K	(m)	-$8.97M
2020-12-31	Reported	-$182.47M	(m)	(m)	(m)	-86.69%	$44.64M	-$129.35M	$185.83M	$4.41M	(m)	-$5.60M
2020-09-30	Rolling	(m)	-$396.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$387.48M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-05-31	Reported	-$68.34M	(m)	(m)	(m)	-16.86%	(m)	-$100.63M	$309.27M	$1.92M	(m)	-$8.35M
2020-03-31	Rolling	(m)	-$344.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	-$288.29M	(m)	(m)	(m)	-172.65%	$73.74M	-$258.06M	$190.47M	$9.17M	(m)	-$8.45M
2019-12-31	Rolling	(m)	-$301.81M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$108.10M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$104.33M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-05-31	Reported	-$121.72M	(m)	(m)	(m)	-67.89%	(m)	-$42.05M	$135.79M	$1.05M	(m)	-$2.04M
2019-03-31	Rolling	(m)	-$82.35M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	-$54.28M	(m)	(m)	(m)	-125.85%	$50.20M	-$46.25M	$28.86M	$5.86M	(m)	-$4.45M
2018-12-31	Rolling	(m)	-$57.65M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$37.35M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$19.52M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$10.85M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	-$5.65M	(m)	(m)	(m)	-27.49%	$10.91M	-$6.00M	(m)	$3.17M	(m)	(m)
2017-12-31	Rolling	(m)	-$7.50M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$5.1M	(m)	(m)	(m)	-40.30%	$488.00K	-$3.32M	(m)	$1.14M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Canopy Growth Corp (CGC)		$0.395B
USANA HEALTH SCIENCES INC (USNA)	United States	$0.264B	-17.90
Niagen Bioscience, Inc. (NAGE)	United States	$0.238B	15.72
FITLIFE BRANDS, INC. (FTLF)	United States	$0.087B	16.59
MANNATECH INC (MTEX)	United States	$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)	United States	$0.011B	-1.16
Synergy CHC Corp. (SNYR)	United States	$0.001B
Functional Brands Inc. (MEHA)	United States	$0.001B
Cronos Group Inc. (CRON)		$1.223B
Definium Therapeutics, Inc. (DFTX)	United States	$4.931B	-17.87